Wells Fargo’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $553K | Buy |
230,470
+222,710
| +2,870% | +$434K | ﹤0.01% | 4541 |
|
|
2026
Q1 | $12.1K | Buy |
7,760
+7,759
| +775,900% | +$11.3K | ﹤0.01% | 5927 |
|
|
2025
Q4 | $1 | Sell |
1
-300
| -100% | -$412 | ﹤0.01% | 7067 |
|
|
2025
Q3 | $406 | Sell |
301
-26,122
| -99% | -$29.6K | ﹤0.01% | 6307 |
|
|
2025
Q2 | $25K | Sell |
26,423
-37,505
| -59% | -$24.3K | ﹤0.01% | 5731 |
|
|
2025
Q1 | $29.5K | Buy |
63,928
+1,405
| +2% | +$886 | ﹤0.01% | 5574 |
|
|
2024
Q4 | $46.2K | Sell |
62,523
-13,966
| -18% | -$16.8K | ﹤0.01% | 5514 |
|
|
2024
Q3 | $120K | Buy |
76,489
+30,888
| +68% | +$55K | ﹤0.01% | 4910 |
|
|
2024
Q2 | $76.6K | Buy |
45,601
+14,586
| +47% | +$26.2K | ﹤0.01% | 5100 |
|
|
2024
Q1 | $74.4K | Buy |
31,015
+4,280
| +16% | +$9.19K | ﹤0.01% | 5065 |
|
|
2023
Q4 | $40.9K | Buy |
26,735
+5,571
| +26% | +$6.62K | ﹤0.01% | 5348 |
|
|
2023
Q3 | $23.1K | Sell |
21,164
-15,661
| -43% | -$27.5K | ﹤0.01% | 5540 |
|
|
2023
Q2 | $84.3K | Buy |
36,825
+21,462
| +140% | +$57K | ﹤0.01% | 5143 |
|
|
2023
Q1 | $37.3K | Buy |
+15,363
| New | +$35.2K | ﹤0.01% | 5321 |
|
|
2022
Q4 | – | Sell |
-761
| Closed | -$2K | – | 7612 |
|
|
2022
Q3 | $2K | Sell |
761
-566
| -43% | -$1.57K | ﹤0.01% | 6164 |
|
|
2022
Q2 | $2K | Sell |
1,327
-178,625
| -99% | -$341K | ﹤0.01% | 6343 |
|
|
2022
Q1 | $376K | Sell |
179,952
-312,779
| -63% | -$867K | ﹤0.01% | 4605 |
|
|
2021
Q4 | $1.94M | Sell |
492,731
-60,232
| -11% | -$293K | ﹤0.01% | 3537 |
|
|
2021
Q3 | $2.66M | Buy |
552,963
+259,555
| +88% | +$1.07M | ﹤0.01% | 3426 |
|
|
2021
Q2 | $1.35M | Buy |
293,408
+244,808
| +504% | +$1.18M | ﹤0.01% | 4007 |
|
|
2021
Q1 | $285K | Sell |
48,600
-8,887
| -15% | -$61.5K | ﹤0.01% | 4993 |
|
|
2020
Q4 | $197K | Sell |
57,487
-92,606
| -62% | -$177K | ﹤0.01% | 5096 |
|
|
2020
Q3 | $216K | Buy |
150,093
+41,426
| +38% | +$73.7K | ﹤0.01% | 4926 |
|
|
2020
Q2 | $217K | Buy |
108,667
+206
| +0.2% | +$404 | ﹤0.01% | 4863 |
|
|
2020
Q1 | $212K | Buy |
108,461
+36,465
| +51% | +$109K | ﹤0.01% | 4649 |
|
|
2019
Q4 | $298K | Buy |
71,996
+49,959
| +227% | +$192K | ﹤0.01% | 4731 |
|
|
2019
Q3 | $66K | Buy |
22,037
+1,193
| +6% | +$3.69K | ﹤0.01% | 5478 |
|
|
2019
Q2 | $131K | Sell |
20,844
-4,408
| -17% | -$26.4K | ﹤0.01% | 5184 |
|
|
2019
Q1 | $141K | Sell |
25,252
-85
| -0.3% | -$516 | ﹤0.01% | 4992 |
|
|
2018
Q4 | $169K | Sell |
25,337
-64
| -0.3% | -$518 | ﹤0.01% | 5023 |
|
|
2018
Q3 | $271K | Buy |
25,401
+300
| +1% | +$3.44K | ﹤0.01% | 4836 |
|
|
2018
Q2 | $301K | Sell |
25,101
-20,823
| -45% | -$213K | ﹤0.01% | 4800 |
|
|
2018
Q1 | $393K | Sell |
45,924
-8,232
| -15% | -$76.1K | ﹤0.01% | 4571 |
|
|
2017
Q4 | $535K | Sell |
54,156
-58,565
| -52% | -$609K | ﹤0.01% | 4344 |
|
|
2017
Q3 | $1.39M | Buy |
112,721
+24,131
| +27% | +$356K | ﹤0.01% | 3598 |
|
|
2017
Q2 | $1.46M | Sell |
88,590
-8,434
| -9% | -$131K | ﹤0.01% | 3442 |
|
|
2017
Q1 | $1.39M | Sell |
97,024
-13,560
| -12% | -$201K | ﹤0.01% | 3490 |
|
|
2016
Q4 | $1.53M | Sell |
110,584
-103,473
| -48% | -$1.66M | ﹤0.01% | 3376 |
|
|
2016
Q3 | $3.87M | Buy |
214,057
+140,953
| +193% | +$2.27M | ﹤0.01% | 2456 |
|
|
2016
Q2 | $1.05M | Sell |
73,104
-2,546
| -3% | -$34.5K | ﹤0.01% | 3456 |
|
|
2016
Q1 | $904K | Buy |
75,650
+59,711
| +375% | +$626K | ﹤0.01% | 3472 |
|
|
2015
Q4 | $212K | Sell |
15,939
-8,627
| -35% | -$106K | ﹤0.01% | 4416 |
|
|
2015
Q3 | $264K | Buy |
24,566
+9,439
| +62% | +$103K | ﹤0.01% | 4315 |
|
|
2015
Q2 | $122K | Buy |
15,127
+11,267
| +292% | +$82.7K | ﹤0.01% | 4919 |
|
|
2015
Q1 | $25K | Buy |
3,860
+1,774
| +85% | +$12.1K | ﹤0.01% | 5296 |
|
|
2014
Q4 | $14K | Buy |
2,086
+13
| +0.6% | +$105 | ﹤0.01% | 5500 |
|
|
2014
Q3 | $21K | Sell |
2,073
-1,090
| -34% | -$11.6K | ﹤0.01% | 5279 |
|
|
2014
Q2 | $35K | Buy |
3,163
+3,020
| +2,112% | +$32.4K | ﹤0.01% | 5107 |
|
|
2014
Q1 | $2K | Sell |
143
-71
| -33% | -$907 | ﹤0.01% | 5686 |
|
|
2013
Q4 | $3K | Sell |
214
-35
| -14% | -$557 | ﹤0.01% | 5479 |
|
|
2013
Q3 | $4K | Buy |
249
+35
| +16% | +$587 | ﹤0.01% | 5333 |
|
|
2013
Q2 | $3K | Buy |
+214
| New | +$3.25K | ﹤0.01% | 5313 |
|
Other funds holding LXRX
AG
SL
SC
Wells Fargo's LXRX Position: Q2 2026 in Review
Wells Fargo increased its Lexicon Pharmaceuticals (LXRX) stake by 2,870% in Q2 2026, buying an estimated $434K and bringing the position to 230,470 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #4541.
Wells Fargo first reported a position in LXRX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.87M in Q3 2016. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.
- Wells Fargo held 230,470 shares of Lexicon Pharmaceuticals worth $553K as of Q2 2026.
- Wells Fargo bought 222,710 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $434K.
- Lexicon Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4541 holding.
- Wells Fargo first reported a position in Lexicon Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Lexicon Pharmaceuticals position peaked at $3.87M in Q3 2016.
- 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.